Atossa Therapeutics
ATOS
#10636
Rank
S$33.96 M
Marketcap
S$3.40
Share price
1.52%
Change (1 day)
248.41%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -S$48.28 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$44.16 Million a decrease over its 2024 earnings that were of -S$32.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$48.28 Million9.32%
2025 -S$44.16 Million36.33%
2024 -S$32.4 Million-15.25%
2023 -S$38.22 Million11.62%
2022 -S$34.24 Million30.84%
2021 -S$26.17 Million15.58%
2020 -S$22.65 Million3.41%
2019 -S$21.9 Million51.16%
2018 -S$14.49 Million40.41%
2017 -S$10.32 Million27.54%
2016 -S$8.09 Million-47.49%
2015 -S$15.41 Million-17.25%
2014 -S$18.62 Million35.91%
2013 -S$13.7 Million112.3%
2012 -S$6.46 Million46.53%
2011 -S$4.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$32.99 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.74 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.74 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$52.93 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.13 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$9.96 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA